Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

DBV Technologies (DBVT) Times Interest Earned (2014 - 2019)

DBV Technologies (DBVT) reported Times Interest Earned of -$1043.3 for Q3 2019, down 282.71% year-over-year from $571.03 in Q3 2018, and down 84.22% on a QoQ basis from -$566.36 in Q4 2018.

DBV Technologies (DBVT) has 5 years of Times Interest Earned data on file, last reported at -$1043.3 in Q3 2019.

  • Quarterly Times Interest Earned fell 282.71% year-over-year to -$1043.3 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was -$2192.6 (changed N/A YoY) and the FY2018 annual result came in at $473.51, up 985.93% from the prior year.
  • Times Interest Earned slipped to -$1043.3 in Q3 2019 per DBVT's latest filing, from -$566.36 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $1299.4 in Q2 2016 and bottomed at -$1043.3 in Q3 2019.
  • The 4-year median for Times Interest Earned is $177.58 (2015), against an average of $87.66.
  • The widest annual swing landed in 2016, when Times Interest Earned soared 631.7%; it then plunged 282.71% in 2019.
  • Tracing DBVT's Times Interest Earned over 4 years: stood at $177.58 in 2015, then jumped by 631.7% to $1299.4 in 2016, then slumped by 143.59% to -$566.36 in 2018, then plunged by 84.22% to -$1043.3 in 2019.
  • Per Business Quant, the three latest DBVT Times Interest Earned figures stand at -$1043.3 (Q3 2019), -$566.36 (Q4 2018), and $571.03 (Q3 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -129.79
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.58
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -258.33
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 11.50
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 49.84
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.88
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2019 -1,043.34
Dec 31, 2018 -566.36
Sep 30, 2018 571.03
Jun 30, 2016 1,299.37
Jun 30, 2015 177.58
Jun 30, 2014 469.14